Filter
427
Text search:
immunocompromised
Featured
Recommendations
54
New Publications
73
Language
Document type
No document type
169
Guidelines
144
Studies & Reports
43
Fact sheets
23
Manuals
22
Strategic & Response Plan
11
Training Material
7
Situation Updates
3
Infographics
3
Brochures
1
Resource Platforms
1
Countries / Regions
India
26
Western and Central Europe
16
Latin America and the Carribbean
13
South Africa
11
Global
9
Africa
8
Kenya
7
Philippines
5
Syria
5
Middle East and North Africa
5
Nigeria
4
Mozambique
4
Ukraine
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Germany
3
Tanzania
3
Rwanda
3
Malawi
3
Brazil
3
East and Southern Africa
3
South–East Asia Region
3
Venezuela
3
Eastern Europe
3
Russia
3
Congo, Democratic Republic of
2
Mali
2
USA
2
Ethiopia
2
Niger
2
Nepal
2
Zambia
2
Indonesia
2
Argentina
2
Myanmar / Burma
2
Chile
2
Yemen
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Ghana
1
Uganda
1
Zimbabwe
1
Haiti
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Chad
1
Mauritania
1
Bangladesh
1
Singapore
1
Sudan
1
Benin
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Western Pacific Region
1
Asia
1
Albania
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Georgia
1
North America
1
France
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
115
Clinical Guidelines
77
Public Health
12
Women & Child Health
12
Key Resources
10
Pharmacy & Technologies
10
Capacity Building
1
Toolboxes
COVID-19
115
TB
59
HIV
31
Rapid Response
23
AMR
22
NTDs
15
Refugee
10
Planetary Health
10
Ebola
7
Cholera
6
Polio
5
Conflict
5
Caregiver
5
Pharmacy
5
Zika
4
Disability
3
Natural Hazards
3
Mental Health
2
Global Health Education
2
Health Financing Toolbox
1
Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrugresistant pathogens, and incr
...
The Government of India is embarking on a mammoth task to prevent COVID-19 spread among communities. The Rapid Evidence Synthesis team received a request to support the planning and development of resources for ensuring preparedness of FLHWs for COVID-19 . The rapid evidence synthesis was conducted
...
Last update: 2 April 2020
Updated guidance. The guidance provides useful information to staff working in prisons, as well as to health and prison authorities, explaining how to prevent and address a potential outbreak of COVID-19. In addition, it aims to protect the health and well-being of all those who live and work in, an
...
Accessed: 02.05.2020
These consolidated guidelines provide recommendations for comprehensive prevention and case management strategies in Kenya
Scope of the Guidelines: Infection prevention and control Patient triage Emergency Medical Services Case management Laboratory testing algorithm
Target
...
This document provides guidance on the implementation of the shielding approach in urban areas in LICs and crisis-affected regions. It is intended for the community itself, national and local governance institutions, and humanitarian and development actors operating in the country.
This document aims to help EU/EEA public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 cases. It outlines the key steps of contact tracing, including contact identification, listing and follow-up, in the context of the COVID-
...
Coronavirus Disease-19 (COVID-19) was declared a global pandemic on 11 March 2020, and Malawi declared its first case on 2 April. As of 30 April, there were 36 confirmed positive cases of COVID-19 and 3 deaths. A State of Disaster was declared by President Arthur Peter Mutharika on 20 March and a 21
...
COVID-19 disproportionately affects the poor and vulnerable. Community health workers are poised to play a pivotal role in fighting the pandemic, especially in countries with less resilient health systems. Drawing from practitioner expertise across four WHO regions, this article outlines the targete
...
This guideline is for:
• health and care practitioners
• health and care staff involved in planning and delivering services
• commissioners.
The recommendations bring together:
• existing national and international guidance and policies
• advice from specialists working in the NHS fr
...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im
...
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga
...
Scientific Brief, 17 June 2020
The COVID-19 pandemic is having far reaching impacts, well beyond the health crisis and needs, with the most severe impacts experienced in the poorest countries and those most vulnerable to humanitarian crises including natural disasters, such as Nepal.
The main objective of this guidance is to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centres in the European Union and European Economic Area (EU/EEA) and the United Kingdom
...
2nd edition
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas
...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people
...
